Funder: Yorkshire Cancer Research. CIs: @jenseligmann, Dion Morton. Sponsor: University of Leeds. Collaborator: University of Birmingham. [email protected]
Leeds, England
Joined May 2019
- Tweets208
- Following80
- Followers587
- Likes134
Halfway there! I'm pleased to announce 10 out of our 20 selected sites have now opened to FOxTROT 4!
Great job to everyone involved!👏👏👏
@LeedsCTRU @JenSeligmann @Janetgr83596731 @PierreFabre @merckgroup
Congratulations to Dr Niki Christou and the team in France who have randomised their first FOxTROT 2 participant! 🎉🎉🎉
I'm also pleased to announce that our Indian team have a total of 4 randomised participants!
An amazing effort by both teams. 👏👏👏
Congratulations to the research team at Lincoln County Hospital who completed The Yorkshire Three Peaks, raising £800 for Yorkshire Cancer Research! 👏👏👏
@yorkshirecancer @Research_ULH
Congratulations to the FOxTROT & ARIEL radiology support team for collecting 2 prestigious awards as top 20 presenters at the ESGAR, Gothenburg. 1st-time winner Dr James Platt delivered an analysis of the accuracy of CT scans for staging bowel cancer, funded by YCR.
Congratulations to the team at Velindre Cancer Centre for randomising our first FOxTROT 4 participant! 🎉🎉🎉
@VelindreTrust @JenSeligmann @Janetgr83596731 @DrSonaliDG @LeedsCTRU
foxtrot-study retweeted
Good article this, not just because it has @FoxtrotStudy in it! But still how often will we STILL have the argument in the MDT about giving NAC in colon cancer.
Sigh. – at Leamington Spa, England
Survival and safety after neoadjuvant chemotherapy or upfront surgery for locally advanced colon cancer: meta-analysis
➡️ doi.org/10.1093/bjs/znae021
This systematic review and meta-analysis of seven studies involving 2120 patients with locally advanced colon cancer found that neoadjuvant chemotherapy is associated with a reduced hazard of recurrence and death, as well as improved 5-year overall survival and disease-free survival rates, compared with upfront surgery. No significant differences in perioperative complications or mortality were found, but neoadjuvant chemotherapy decreased the risk of incomplete resection.
In conclusion, neoadjuvant chemotherapy appears to offer oncological benefits in the treatment of locally advanced colon cancer.
Great work by @ClinicaNavarra - Daniel Aliseda, Jorge Arredondo, Carlos Sánchez-Justicia, Alicia Alvarellos, Javier Rodríguez, Ignacio Matos, Fernando Rotellar, Jorge Baixauli, Carlos Pastor
#SoMe4Surgery #MedTwitter #SurgEd #Surgery @RCPSGTrainees @aecirujanos @SEIQuirurgica @iss_sic #MedicalTechniques @BJSAcademy @young_bjs @BJSOpen @des_winter @evanscolorectal @robhinchliffe1 @bplwijn @ksoreide @MalinASund @nfmkok @TejedorPat @paulo_sutt @PVaughanShaw @JJEarnshaw @juliomayol #colorectalsurgery #StepUp4CRC @FightCRC @ACPGBI @Dukes_Club@ACPGBI_EduTrain@escp_tweets @YouESCP
foxtrot-study retweeted
A good article.. but let’s not forget @FoxtrotStudy had all comers enrolled at T3-4 N1/2 whereas HIPECT only enrolled T4 at baseline… – at Leamington Spa, England
Our recent commentary of the HIPECT4 trial and current evidence for patients with advanced colon cancer
@UHSurgOncology @UH_RE_Institute @AmmoriJohn @LukeRothermel @JordanMWinterMD @RonCharlesMD @doctorc369 acsjournals.onlinelibrary.wi…
A big thank you to @PierreFabre and @merckgroup for providing the support to make this possible!
We are delighted to announce that The Beatson has officially opened to FOxTROT 4!!! 🎉
Well done to everybody involved in making this happen!
Information about FOxTROT 4 can be found in the link below.
isrctn.com/ISRCTN83842641
@JenSeligmann @Janetgr83596731 @NHSGGC @LeedsCTRU
We are delighted to announce that The Beatson has officially opened to FOxTROT 4!!! 🎉
Well done to everybody involved in making this happen!
Information about FOxTROT 4 can be found in the link below.
isrctn.com/ISRCTN83842641
@JenSeligmann @Janetgr83596731 @NHSGGC @LeedsCTRU
foxtrot-study retweeted
ONCOLOGISTS - we have an associate prof post available!
Work with us in Birmingham and get access to one of the largest Oncology units in the UK
More details in my LinkedIn post here - linkedin.com/posts/andrew-be…
Or job is here:
edzz.fa.em3.oraclecloud.com/…
The FOxTROT 2 and 3 studies are generously funded by Yorkshire Cancer Research @yorkshirecancer - a huge thank you to the charity and all its supporters.
The FOxTROT Platform is a programme of studies run by @LeedsCTRU @UniversityLeeds aiming to personalise neo-adjuvant chemotherapy in locally advanced but operable colon cancer. FOxTROT 4, and more, will be coming soon - watch this space!